Chao Family Comprehensive Cancer Center Pilot Projects
New 2014 pilot project grants invest $472,537 in cancer research across UC Irvine
The Chao Family Comprehensive Cancer Center (CFCCC) has awarded eight new pilot projects: four cooperative group projects and four pipeline award projects.
The Chao Family Comprehensive Cancer Center (CFCCC) at UC Irvine invited proposals from its members for an expanded seed grant funding program for the Academic Year 2014-2015. Eligibility was limited to current CFCCC membership. Two areas of particular need and emphasis were identified:
- To increase the number of extramural collaborative grant applications and awards (for example: dual-PI R01s, P01s, U01s, LLS SCOR grants, etc.);
- To prioritize and promote the advancement of novel diagnostic or screening technologies, therapeutic molecules or devices, and biobehavioral interventions through the translational pipeline towards clinical application. This includes support for development of investigator-initiated clinical trials by clinical investigators.
The center received 30 grant applications. After a rigorous review process grants were awarded to the following highly qualified projects:
- Advancing Targeted Therapies for Hematologic Neoplasm
- Principal Investigators: Aimee Edinger, Angela Fleischman, David Fruman and Richard Van Etten
- Clinical Evaluation of a New Circulating Tumor Cell Test for Monitoring Colorectal Cancer
- Principal Investigators: Jason Zell and Weian Zhao
- Circadian Clock Regulation and Skin Cancer
- Principal Investigators: Bogi Andersen, Paolo Sassone-Corsi, Anand Ganesan, Xing Dai, Maksim Plikus and Alexander Boiko
- Histone Methyltransferase and Structure-based Drug Design
- Principal Investigators: Tom Poulos and Larry Overman
- A Multimodality Imaging Approach For Breast Cancer: Combined MRI and Fluorescence Optical Tomography
- Principal Investigator: Gultekin Gulsen
- Multi-Channel Virus Biosensor for Rapid Quantitation of Six Candidate Bladder Cancer Markers in Urine
- Principal Investigators: Reginald Penner and Gregory Weiss
- Phase I Study Of Corydalis Yanhusuo to Manage Symptoms of Peripheral Chemotherapy-induced Neuropathy
- Principal Investigators: Edward Nelson and Tara Seery
- Reducing Unnecessary Breast Biopsies with Noninvasive Diffuse Optical Spectroscopy
- Principal Investigator: Bruce Tromberg
On an annual basis — and more often as additional funds allow — the CFCCC distributes an RFP to Cancer Center members via email and this website.
Please contact Brian McClendon at email@example.com if you have a question about the CFCCC Pilot Projects Program.